A moot court on “The Value of Health Data” !

Published on: June 4, 2023
Categories: News

At this year’s Computer, Privacy and Data Protection Conference (CPDP) taking place from 24th-26th of May in Brussels, Clara Saillant and Theresa Henne from the Institute of Digitalisation and Innovation in Law organized a moot court on the topic “The Value of Health Data”. The fictional court case was inspired by discussions taking place in the Horizon 2020 project ProCAncer-I, which gathers 20 excellent technical, clinical and legal partners from all over Europe to build a data repository for MRI images of prostate cancer. Furthermore, the project aims at developing AI models assisting clinicians in the detection, diagnosis and treatment of prostate cancer

 

In the development process, a crucial question is how the contribution of clinical data providers to the development of AI technology should be rewarded within the project – a matter that is also currently discussed on EU level as part of the drafting process of the European Health Data Space. In the video recording, you can become witness to a fictional court proceeding, in which a clinical data provider and a patient representative group sue an AI company. The moot-court was conducted in a workshop format, in which participant could join one of the three parties and discuss in the group how to make the best argument in order to convince the judge. In the video, only the three rounds of statements are recorded, whereas the group discussions are left out. A big huge to María José Alarte Aceñero, Head of Legal at Quibim, Aline Blankertz from Wikimedia Germany, Daniele Regge, Associate Professor in Radiology, University of Torino and Lorraine Maisnier-Boché from McDermott Will & Emery for bringing out moot court to live with their fantastic performance as one of the Court parties and the judge!

 

Highlights

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...

Stay in touch!